Clinigen Share Chat (CLIN)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Clinigen Group	LSE:CLIN	London	Ordinary Share	GB00B89J2419	ORD 0.1P

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	-3.00p	-0.33%	904.00p	904.00p	905.00p	914.50p	900.00p	913.50p	44,532	11:10:29

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Pharmaceuticals & Biotechnology	302.3	14.1	3.3	273.9	1,105.30

Clinigen Share Discussion Threads

Showing 926 to 948 of 950 messages

Chat Pages: 38 37 36 35 34 33 32 31 30 29 28 27 Older

Date	Subject	Author	Discuss
20/4/2018 12:38	any kick up from the dexrazoxane shortage?	r ball	Read Full Thread Reply
10/4/2018 16:16	Nice rise.....more to come though !! GLA	gerrym two	Read Full Thread Reply
03/4/2018 07:43	"One of ICs tips of the week." That will be the kiss of death then..	bulltradept	Read Full Thread Reply
29/3/2018 11:55	This stock should be changed to Bill Murray because its like Groundhog and day watching the share price	maestrovitch666	Read Full Thread Reply
29/3/2018 11:10	Rated very highly overall and still performing awfully so what's going on? I am certain the brokers and the company executives stroke a deal to agree on pumping shiz.	maestrovitch666	Read Full Thread Reply
29/3/2018 09:21	One of ICs tips of the week.	mfhmfh	Read Full Thread Reply
29/3/2018 09:21	One of ICs tips of the week.	mfhmfh	Read Full Thread Reply
27/3/2018 13:57	Need to clear the seller IMHO	mfhmfh	Read Full Thread Reply
27/3/2018 13:16	WTF AND is wrong with this stock? I Two good pieces of news and buy ratings from prestigious brokerages and its dead in the water. FFS	maestrovitch666	Read Full Thread Reply
26/3/2018 11:04	Clinigen to present to investors at the upcoming Proactive One2One Healthcare Forum on 5th April in London. For details and registration, click here: https://tinyurl.com/ybpqtpjg	aim_trader	Read Full Thread Reply
21/3/2018 22:58	Needs to go back up past 1150p to resume its momentum and performance trend of the last two years. With revenues up 28% in the 6 months to December 17, cash and eps up considerably more and the "specials" acquisition still kicking in, this looks attainable.	arc en ciel	Read Full Thread Reply
20/3/2018 19:07	Bought two tranches last two days ! This will go back to 10 quid +	gerrym two	Read Full Thread Reply
20/3/2018 04:52	Adding here.	lomax99	Read Full Thread Reply
19/3/2018 23:26	Double bottom hit at the close today at ca 890p. No news. Next move? Straight back up to 1,100p + in my book!	arc en ciel	Read Full Thread Reply
06/3/2018 08:20	Old Mutual above 6%	mfhmfh	Read Full Thread Reply
05/3/2018 09:49	thank you looks good thus far - think we will see 1200p by May?	maestrovitch666	Read Full Thread Reply
04/3/2018 14:29	The UT Trade at 915p will have been the last trade of the day & this will be after the Auction & the mid-price close. The other trades will have been made earlier in the day but just processed after the close.	martinthebrave	Read Full Thread Reply
04/3/2018 10:55	One thing that does concern me is the huge amount of sells after hours - Do we expect CLIN to open significantly down on Monday March 5th ?	maestrovitch666	Read Full Thread Reply
02/3/2018 11:26	IC says buy today too fwiw	value viper	Read Full Thread Reply
02/3/2018 11:24	Just done at 908.5. Not easy to deal.	123prezzie	Read Full Thread Reply
02/3/2018 11:13	upgraded to BUY - BERENBERG & PEEL HUNT - Target - £12.50-£13.50 so yes a good time to top up methinks. What say you chaps?	maestrovitch666	Read Full Thread Reply
01/3/2018 17:25	healthtech. We're below the 900 mark now. I agree with you and may well add. There's plenty of mileage in this type of business. APH has taken a similar path (although much more slowly) with out of patent healthcare products which the big players don't want. I would prefer to see the directors holding more shares, Peter George having become an NED and selling a big chunk. Joihn Dawson at APH has also become an NED but seems to be holding onto his significant stake.	123prezzie	Read Full Thread Reply
01/3/2018 16:44	Overreaction. Commercial Medicines division is storming ahead and expected to grow further with Quantum Pharma pipeline. Clinical Trials Services gross profits dropped, which is what's driving this share price fall. At sub-900p, I'll buy more.	healthtech	Read Full Thread Reply

Chat Pages: 38 37 36 35 34 33 32 31 30 29 28 27 Older